# Efficacy and Safety of Mirabegron Versus Oxybutynin After Posterior Urethral Valve Ablation

> **NCT07668232** · NA · COMPLETED · sponsor: **South Valley University** · enrollment: 52 (actual)

## Conditions studied

- Posterior Urethral Valve

## Interventions

- **DRUG:** Mirabegron

## Key facts

- **NCT ID:** NCT07668232
- **Lead sponsor:** South Valley University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-01
- **Primary completion:** 2025-12-15
- **Final completion:** 2025-12-30
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668232, "Efficacy and Safety of Mirabegron Versus Oxybutynin After Posterior Urethral Valve Ablation". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*